Exam 1 - Random Info Flashcards
6-MP polymorphism
TPMT loss of function
cytarabine synergy agent
a. leucovorin
b. tetrahydrouridine
c. dexrazoxane
d. 5-FU
b. tetrahydrouridine
cisplatin toxicity
nephrotoxicity
irinotecan polymorphism
a. TPMT
b. UGT1A1
c. BRAF-V600
d. T315l
b. UGT1A1
drug given with doxorubicin to protect against anthracycline-induced cardiotoxicity
dexrazoxane
bleomycin main toxicity
pulmonary
which has a lower rate of neurotoxicity?
a. vincristine
b. eribulin
b. eribulin
formulation for GnRH analogs for breast cancer (i.e. leuprolide)
depot
which drug does not result in “flare” of testosterone production?
a. leuprolide
b. goserelin
c. triptorelin
d. degarelix
d. degarelix
common SE of abiraterone
inc cholesterol levels
what drug inhibits the function of 17 alpha-hydroxylase and C17,20 lyase?
a. abiraterone
b. fulvestrant
c. exemestane
d. alectinib
a. abiraterone
drug that can inhibit the “gatekeeper” T315l mutation
a. alectinib
b. quizartinib
c. ponatinib
d. dabrafenib
c. ponatinib
drug that is specific for internal tandem duplication (ITD) mutations
a. sirolimus
b. alectinib
c. quizartinib
d. trametinib
c. quizartinib
which drug inhibits immune response by blocking IL-2 signaling transduction?
a. sirolimus
b. dabrafenib
c. trametinib
d. afatinib
a. sirolimus
which drug is a type III allosteric kinase inhibitor?
a. gefitinib
b. alectinib
c. trametinib
d. acalabrutinib
c. trametinib
what drug is used in combo with trametinib for BRAFV600E mutant metastatic melanoma?
dabrafenib
kinase inhibitor that is effective for T790M mutation
a. trametinib
b. lapatinib
c. tucatinib
d. osimertinib
d. osimertinib
drug that is EGFR and HER2 reversible inhibitor
lapatinib